Surgical treatment of the primary tumour improves the overall survival in patients with metastatic breast cancer: A systematic review and meta-analysis, Molecular and Clinical Oncology, vol.4, issue.5, pp.863-867, 2016. ,
DOI : 10.3892/mco.2016.778
Assessing the role of primary tumour resection in patients with synchronous unresectable liver metastases from pancreatic neuroendocrine tumour of the body and tail. A propensity score survival evaluation, European Journal of Surgical Oncology (EJSO), vol.43, issue.2, 2016. ,
DOI : 10.1016/j.ejso.2016.09.011
Simultaneous Resections of Colorectal Cancer and Synchronous Liver Metastases: A Multi-institutional Analysis, Annals of Surgical Oncology, vol.129, issue.12, pp.3481-91, 2007. ,
DOI : 10.1245/s10434-007-9522-5
Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases, Surgery, vol.136, issue.3, pp.650-659, 2004. ,
DOI : 10.1016/j.surg.2004.02.012
Simultaneous versus staged liver resection of synchronous liver metastases from colorectal cancer, International Journal of Colorectal Disease, vol.19, issue.10, pp.1269-76, 2007. ,
DOI : 10.1007/s00384-007-0286-y
Comparison of simultaneous or delayed liver surgery for limited synchronous colorectal metastases, British Journal of Surgery, vol.14, issue.8, pp.1279-89, 2010. ,
DOI : 10.1007/978-3-642-51873-7
Operation in patients with incurable colon cancer???Is it worthwhile?, Diseases of the Colon & Rectum, vol.40, issue.1, pp.11-15, 1997. ,
DOI : 10.1007/BF02055675
How aggressive should we be in patients with stage iv colorectal cancer?, Diseases of the Colon & Rectum, vol.46, issue.12, pp.1646-52, 2003. ,
DOI : 10.1007/BF02660770
Initial Presentation With Stage IV Colorectal Cancer, Archives of Surgery, vol.135, issue.5, pp.530-534, 2000. ,
DOI : 10.1001/archsurg.135.5.530
URL : http://archsurg.jamanetwork.com/data/journals/surg/9430/sws9020.pdf
Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary, British Journal of Surgery, vol.231, issue.7, pp.872-880, 2006. ,
DOI : 10.1002/bjs.5346
A Survival Analysis of the Liver-First Reversed Management of Advanced Simultaneous Colorectal Liver Metastases, Annals of Surgery, vol.256, issue.5, pp.772-780, 2012. ,
DOI : 10.1097/SLA.0b013e3182734423
Surgical Strategies for Synchronous Colorectal Liver Metastases in 156 Consecutive Patients: Classic, Combined or Reverse Strategy?, Journal of the American College of Surgeons, vol.210, issue.6, pp.934-975, 2010. ,
DOI : 10.1016/j.jamcollsurg.2010.02.039
Surgical Management of Patients with Synchronous Colorectal Liver Metastasis: A Multicenter International Analysis, Journal of the American College of Surgeons, vol.216, issue.4, pp.707-723, 2013. ,
DOI : 10.1016/j.jamcollsurg.2012.12.029
Feasibility of the liver-first approach for patients with initially unresectable and not optimally resectable synchronous colorectal liver metastases, Surgery Today, vol.19, issue.6, 2015. ,
DOI : 10.1245/s10434-011-2061-0
Preliminary Results of ???Liver-First' Reverse Management for Advanced and Aggressive Synchronous Colorectal Liver Metastases: A Propensity-Matched Analysis, Digestive Surgery, vol.32, issue.1, pp.16-22, 2015. ,
DOI : 10.1159/000370253
Propensity score-matched outcomes analysis of the liver-first approach for synchronous colorectal liver metastases, British Journal of Surgery, vol.96, issue.5, pp.600-606, 2016. ,
DOI : 10.1038/sj.bjc.6603670
The Hallmarks of Cancer, Cell, vol.100, issue.1, pp.57-70, 2000. ,
DOI : 10.1016/S0092-8674(00)81683-9
Hallmarks of Cancer: The Next Generation, Cell, vol.144, issue.5, pp.646-74, 2011. ,
DOI : 10.1016/j.cell.2011.02.013
[Microenvironment and colorectal liver metastases angiogenesis: surgical implications], Bull Cancer, vol.100, issue.4, pp.343-50, 2013. ,
URL : https://hal.archives-ouvertes.fr/tel-01784875
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche Angiogenesis in synchronous and metachronous colorectal liver metastases: the liver as a permissive soil, Nature Ann Surg, vol.438, issue.2551, pp.820-786, 2005. ,
Metastasis: Metastasis to bone: causes, consequences and therapeutic opportunities, Nature Reviews Cancer, vol.2, issue.8, pp.584-93, 2002. ,
DOI : 10.1038/nrc867
Angiogenesis: Tumorigenesis and the angiogenic switch, Nature Reviews Cancer, vol.3, issue.6, pp.401-411, 2003. ,
DOI : 10.1038/nrc1093
Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis., Journal of Clinical Investigation, vol.95, issue.4, pp.1789-97, 1995. ,
DOI : 10.1172/JCI117857
Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer, British Journal of Cancer, vol.78, issue.10, pp.1379-84, 1998. ,
DOI : 10.1038/bjc.1998.688
VEGF as a Key Mediator of Angiogenesis in Cancer, Oncology, vol.45, issue.3, pp.4-10, 2005. ,
DOI : 10.1038/nm988
VEGF as a Therapeutic Target in Cancer, Oncology, vol.288, issue.3, pp.11-17, 2005. ,
DOI : 10.1056/NEJMoa032691
Vessel Counts and Expression of Vascular Endothelial Growth Factor as Prognostic Factors in Node-Negative Colon Cancer, Archives of Surgery, vol.132, issue.5, pp.541-547, 1997. ,
DOI : 10.1001/archsurg.1997.01430290087018
Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer, British Journal of Cancer, vol.77, issue.6, pp.998-1002, 1998. ,
DOI : 10.1038/bjc.1998.164
Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer, Cancer Res, vol.61, issue.24, pp.8664-8671, 2001. ,
Cyclooxygenase 2-and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in Apc(Delta716) mouse intestinal polyps, Cancer Res, vol.62, issue.2, pp.506-517, 2002. ,
Impact of oncogenes in tumor angiogenesis: Mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells, Proceedings of the National Academy of Sciences, vol.18, issue.1, pp.3609-3623, 1998. ,
DOI : 10.1128/MCB.18.1.85
Tumor Angiogenesis as a Prognostic Predictor in Colorectal Carcinoma with Special Reference to Mode of Metastasis and Recurrence, Oncology, vol.55, issue.6, pp.575-81, 1998. ,
DOI : 10.1159/000011915
Tumor Angiogenesis as a Predictor of Recurrence and Survival in Patients with Node-Negative Colon Cancer, Annals of Surgery, vol.222, issue.6, pp.695-704, 1995. ,
DOI : 10.1097/00000658-199512000-00002
Microvessel quantification and its possible relation with liver metastasis in colorectal cancer, Cancer, vol.43, issue.8, pp.1722-1730, 1996. ,
DOI : 10.1136/jcp.43.9.752
Randomized, Controlled Trial of Irinotecan Plus Infusional, Bolus, or Oral Fluoropyrimidines in First-Line Treatment of Metastatic Colorectal Cancer: Updated Results From the BICC-C Study, Journal of Clinical Oncology, vol.26, issue.4, pp.689-90, 2008. ,
DOI : 10.1200/JCO.2007.15.5390
Bevacizumab in Combination With Fluorouracil and Leucovorin: An Active Regimen for First-Line Metastatic Colorectal Cancer, Journal of Clinical Oncology, vol.23, issue.15, pp.3502-3510, 2005. ,
DOI : 10.1200/JCO.2005.10.017
Combined Analysis of Efficacy: The Addition of Bevacizumab to Fluorouracil/Leucovorin Improves Survival for Patients With Metastatic Colorectal Cancer, Journal of Clinical Oncology, vol.23, issue.16, pp.3706-3718, 2005. ,
DOI : 10.1200/JCO.2005.00.232
Addition of Bevacizumab to Bolus Fluorouracil and Leucovorin in First-Line Metastatic Colorectal Cancer: Results of a Randomized Phase II Trial, Journal of Clinical Oncology, vol.23, issue.16, pp.3697-705, 2005. ,
DOI : 10.1200/JCO.2005.05.112
Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study, Journal of Clinical Oncology, vol.26, issue.12, pp.2013-2022, 2008. ,
DOI : 10.1200/JCO.2007.14.9930
Microenvironmental regulation of metastasis, Nature Reviews Cancer, vol.19, issue.4, pp.239-52, 2009. ,
DOI : 10.1053/sonc.2002.37263
Bone Marrow Origin of Endothelial Progenitor Cells Responsible for Postnatal Vasculogenesis in Physiological and Pathological Neovascularization, Circulation Research, vol.85, issue.3, pp.221-229, 1999. ,
DOI : 10.1161/01.RES.85.3.221
Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization, Nature Medicine, vol.121, issue.4, pp.434-442, 1999. ,
DOI : 10.1161/01.RES.83.3.233
Impaired recruitment of bone-marrow???derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth, Nature Medicine, vol.88, issue.11, pp.1194-201, 2001. ,
DOI : 10.1161/01.RES.88.2.167
Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?, Nature Reviews Cancer, vol.91, issue.11, pp.826-861, 2002. ,
DOI : 10.1161/01.RES.0000026420.22406.79
CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer, Journal of Clinical Pathology, vol.57, issue.9, pp.965-974, 2004. ,
DOI : 10.1136/jcp.2004.016444
Origins of circulating endothelial cells and endothelial outgrowth from blood, Journal of Clinical Investigation, vol.105, issue.1, pp.71-78, 2000. ,
DOI : 10.1172/JCI8071
Circulating Endothelial Cells, Endothelial Progenitor Cells, and Endothelial Microparticles in Cancer, Neoplasia, vol.8, issue.2, pp.79-88, 2006. ,
DOI : 10.1593/neo.05592
Circulating endothelial progenitor cells correlate to stage in patients with invasive breast cancer, Breast Cancer Research and Treatment, vol.66, issue.3, pp.133-141, 2008. ,
DOI : 10.1161/01.RES.88.2.167
Endothelial progenitor cells in breast cancer patients, Breast Cancer Research and Treatment, vol.2, issue.3, pp.343-352, 2007. ,
DOI : 10.1161/01.RES.88.2.167
Circulating endothelial cells predict for response to bevacizumab-based chemotherapy in metastatic colorectal cancer, Cancer Chemotherapy and Pharmacology, vol.15, issue.3, pp.763-771, 2010. ,
DOI : 10.1158/1078-0432.CCR-09-1493
Clinical value of circulating endothelial cell levels in metastatic colorectal cancer patients treated with first-line chemotherapy and bevacizumab ???, Annals of Oncology, vol.27, issue.5, pp.919-946, 2011. ,
DOI : 10.1200/JCO.2008.20.2879
Prognostic value of circulating VEGFR2+ bone marrow-derived progenitor cells in patients with advanced cancer, European Journal of Cancer, vol.48, issue.9, pp.1354-62, 2012. ,
DOI : 10.1016/j.ejca.2012.01.021
Circulating endothelial cells: biomarkers for monitoring activity of antiangiogenic therapy], Bull Cancer, vol.94, pp.254-263, 2007. ,
The multifaceted circulating endothelial cell in cancer: towards marker and target identification, Nature Reviews Cancer, vol.438, issue.Suppl. 16, pp.835-880, 2006. ,
DOI : 10.1038/nature04186
Preparing the "Soil": The Premetastatic Niche, Cancer Research, vol.66, issue.23, pp.11089-93, 2006. ,
DOI : 10.1158/0008-5472.CAN-06-2407
The metastatic niche: adapting the foreign soil, Nature Reviews Cancer, vol.3, issue.4, pp.285-93, 2009. ,
DOI : 10.4161/cc.5.11.2775
MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis, Cancer Cell, vol.2, issue.4, pp.289-300, 2002. ,
DOI : 10.1016/S1535-6108(02)00153-8
The S100A8???serum amyloid A3???TLR4 paracrine cascade establishes a pre-metastatic phase, Nature Cell Biology, vol.17, issue.11, pp.1349-55, 2008. ,
DOI : 10.1161/01.ATV.17.8.1599
Tumor Angiogenesis and Metastasis ??? Correlation in Invasive Breast Carcinoma, New England Journal of Medicine, vol.324, issue.1, pp.1-8, 1991. ,
DOI : 10.1056/NEJM199101033240101
Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: An immunohistochemical study, The Journal of Pathology, vol.548, issue.2, pp.183-90, 1995. ,
DOI : 10.1007/978-1-4613-2449-2_31
Quantitative analysis of the epithelial lining architecture in radicular cysts and odontogenic keratocysts Comparison of quantification of histochemical staining by hue-saturation-intensity (HSI) transformation and color-deconvolution, Head Face Med, vol.2, 2006. ,
Architectural analysis of oral cancer, dysplastic, and normal epithelia, Cytometry, vol.194, issue.1, pp.45-55, 2004. ,
DOI : 10.1007/978-3-0348-8501-0_17
Isolation of Putative Progenitor Endothelial Cells for Angiogenesis, Science, vol.149, issue.5302, pp.964-971, 1997. ,
DOI : 10.1016/0006-291X(91)91276-I
Only a specific subset of human peripheral-blood monocytes has endothelial-like functional capacity, Blood, vol.106, issue.7, pp.2347-55, 2005. ,
DOI : 10.1182/blood-2005-04-1407
Characterization of Two Types of Endothelial Progenitor Cells and Their Different Contributions to Neovasculogenesis, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.24, issue.2, pp.288-93, 2004. ,
DOI : 10.1161/01.ATV.0000114236.77009.06
Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood, Blood, vol.104, issue.9, pp.2752-60, 2004. ,
DOI : 10.1182/blood-2004-04-1396
Peripheral Blood "Endothelial Progenitor Cells" Are Derived From Monocyte/Macrophages and Secrete Angiogenic Growth Factors, Circulation, vol.107, issue.8, pp.1164-1173, 2003. ,
DOI : 10.1161/01.CIR.0000058702.69484.A0
URL : http://circ.ahajournals.org/content/circulationaha/107/8/1164.full.pdf
Relevance of Monocytic Features for Neovascularization Capacity of Circulating Endothelial Progenitor Cells, Circulation, vol.108, issue.20, pp.2511-2517, 2003. ,
DOI : 10.1161/01.CIR.0000096483.29777.50
Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals, Blood, vol.109, issue.5, pp.1801-1810, 2007. ,
DOI : 10.1182/blood-2006-08-043471
Specific genomic aberrations in primary colorectal cancer are associated with liver metastases, BMC Cancer, vol.6, issue.1, pp.662-73195, 2008. ,
DOI : 10.1016/j.cancergencyto.2005.12.011
Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells, Cancer Res, vol.63, issue.15, pp.4342-4348, 2003. ,
Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; Implications for cellular surrogate marker analysis of antiangiogenesis, Cancer Cell, vol.7, issue.1, pp.101-112, 2005. ,
Ischemia-reperfusion of small liver remnant promotes liver tumor growth and metastases???Activation of cell invasion and migration pathways, Liver Transplantation, vol.160, issue.12, pp.1669-77, 2007. ,
DOI : 10.1016/S0039-6060(98)70075-3
Warm Hepatic Ischemia-Reperfusion Promotes Growth of Colorectal Carcinoma Micrometastases in Mouse Liver via Matrix Metalloproteinase-9 Induction, Cancer Research, vol.67, issue.6, pp.2720-2728, 2007. ,
DOI : 10.1158/0008-5472.CAN-06-3923
CD95 is a key mediator of invasion and accelerated outgrowth of mouse colorectal liver metastases following radiofrequency ablation Ischemia/reperfusion accelerates the outgrowth of hepatic micrometastases in a highly standardized murine model Perinecrotic hypoxia contributes to ischemia/reperfusion-accelerated outgrowth of colorectal micrometastases, J Hepatol Hepatology Am J Pathol, vol.53, issue.1704, pp.1069-77165, 2005. ,
Does Hepatic Pedicle Clamping Affect Disease-Free Survival Following Liver Resection for Colorectal Metastases?, Annals of Surgery, vol.252, issue.6, pp.1020-1026, 2010. ,
DOI : 10.1097/SLA.0b013e3181f66918
Hepatic Pedicle Clamping During Hepatic Resection for Colorectal Liver Metastases: No Impact on Survival or Hepatic Recurrence, Annals of Surgical Oncology, vol.238, issue.6, pp.285-94, 2012. ,
DOI : 10.1097/01.sla.0000098620.27623.7d